Your session is about to expire
← Back to Search
Polyphenol
Grape Seed Extract for Prostate Cancer
N/A
Waitlist Available
Led By Paul Maroni, MD
Research Sponsored by University of Colorado, Denver
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Histologically confirmed prostate adenocarcinoma
Evidence of rising PSA, on 2 separate occasions, at least one week apart. Baseline PSA must be ≥ 0.2 ng/mL at the time of screening. Radiographic evidence of disease is not allowed
Must not have
Patients who are on active surveillance for untreated localized disease may not participate in this study
Very fast PSA doubling time of less than 4 weeks, if the absolute PSA is > 2 ng/mL
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6 weeks and 3, 6, 9, and 12 months
Awards & highlights
No Placebo-Only Group
Summary
This trial involves patients taking a grape seed extract supplement to help manage their prostate health. The supplement is believed to protect cells and reduce inflammation. Patients' PSA levels will be monitored to assess the effectiveness of the treatment.
Who is the study for?
This trial is for adults over 18 with prostate cancer who've seen a rise in PSA after local therapy, not on active hormone therapies, and have declined or aren't candidates for salvage therapy. They must be able to swallow capsules, have no severe allergies to GSE products, and not be on surveillance for untreated localized disease.
What is being tested?
The study tests the effects of Grape Seed Extract (GSE) taken orally at 150 mg twice daily. Participants will take GSE for up to one year with evaluations every six weeks initially and then every three months.
What are the potential side effects?
Potential side effects are not explicitly listed but may include typical reactions to supplements such as digestive issues or allergic responses in those sensitive to grape seed extract components.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
My prostate cancer was confirmed through a tissue examination.
Select...
My PSA levels have increased on two tests done a week apart, with a baseline of at least 0.2 ng/mL, and I have no visible cancer on scans.
Select...
I am not on hormone therapy for cancer and my testosterone is above 50 ng/dL.
Select...
I am able to care for myself and perform daily activities.
Select...
My blood counts meet the required levels for treatment.
Select...
My liver tests are within the required range.
Select...
I am 18 years old or older.
Select...
My kidney function is within the normal range.
Exclusion Criteria
You may be eligible for the trial if you check “No” for criteria below:Select...
I am not just being watched for my untreated localized disease.
Select...
My PSA levels are rising very quickly.
Select...
I cannot swallow pills or have a condition affecting my stomach's ability to absorb medicine.
Select...
I need strong painkillers for my prostate cancer pain.
Select...
I haven't had major surgery, radiation, or experimental drugs in the last 2 weeks.
Select...
I have a chronic HIV or hepatitis infection.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 6 weeks and 3, 6, 9, and 12 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6 weeks and 3, 6, 9, and 12 months
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
The number of patients with PSA response
Secondary study objectives
The rate of change of the PSA over time (PSA velocity) for each patient
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
1Treatment groups
Experimental Treatment
Group I: 150 mg of Grape Seed Extract (GSE)Experimental Treatment1 Intervention
150 mg of GSE twice daily in the form of 75 mg capsule of Leucoselect Phytosome preparation.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Grape Seed Extract
2008
Completed Phase 1
~110
Research Highlights
Information in this section is not a recommendation. We encourage patients to speak with their healthcare team when evaluating any treatment decision.Mechanism Of Action
Side Effect Profile
Prior Approvals
Other Research
Common treatments for prostate cancer include surgery, radiation therapy, hormone therapy, chemotherapy, and emerging treatments like antioxidants. Antioxidants, such as Grape Seed Extract (GSE), work by neutralizing free radicals, thereby reducing oxidative stress and potentially slowing cancer progression.
This is particularly relevant for prostate cancer patients as oxidative stress is implicated in cancer development and progression. By mitigating oxidative damage, antioxidants may help in managing prostate cancer, especially in cases where traditional treatments are not suitable or as complementary therapies to enhance overall treatment efficacy.
Establishing the infrastructure to conduct comparative effectiveness research toward the elimination of disparities: a community-based participatory research framework.Specialty supplements and prostate cancer risk in the VITamins and Lifestyle (VITAL) cohort.Phase II study of pomegranate juice for men with rising prostate-specific antigen following surgery or radiation for prostate cancer.
Establishing the infrastructure to conduct comparative effectiveness research toward the elimination of disparities: a community-based participatory research framework.Specialty supplements and prostate cancer risk in the VITamins and Lifestyle (VITAL) cohort.Phase II study of pomegranate juice for men with rising prostate-specific antigen following surgery or radiation for prostate cancer.
Find a Location
Who is running the clinical trial?
University of Colorado, DenverLead Sponsor
1,805 Previous Clinical Trials
2,822,405 Total Patients Enrolled
13 Trials studying Prostate Cancer
2,987 Patients Enrolled for Prostate Cancer
Cancer League of ColoradoOTHER
11 Previous Clinical Trials
371 Total Patients Enrolled
1 Trials studying Prostate Cancer
30 Patients Enrolled for Prostate Cancer
Paul Maroni, MDPrincipal InvestigatorUniversity of Colorado, Denver
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I am able to care for myself and perform daily activities.My PSA levels are rising very quickly.I cannot swallow pills or have a condition affecting my stomach's ability to absorb medicine.I am not just being watched for my untreated localized disease.I have had cancer before, but it's either cured or not life-threatening in the next 3 years.My prostate cancer was confirmed through a tissue examination.My PSA levels have increased on two tests done a week apart, with a baseline of at least 0.2 ng/mL, and I have no visible cancer on scans.I am not on hormone therapy for cancer and my testosterone is above 50 ng/dL.I am not on any prostate cancer hormone treatments or medications for shrinking the prostate.I have discussed or considered local salvage therapy but chose not to proceed or was not eligible.My prostate cancer has returned after initial treatment.I have hormone-sensitive cancer and have had hormone therapy before.My blood counts meet the required levels for treatment.My liver tests are within the required range.I agree not to start new herbal supplements during the study.I've had chemotherapy for prostate cancer, but not for hormone-resistant types.I am 18 years old or older.I need strong painkillers for my prostate cancer pain.I haven't had major surgery, radiation, or experimental drugs in the last 2 weeks.I have at least 3 PSA test results from the last 6 months to calculate my PSA doubling time.My kidney function is within the normal range.I have a chronic HIV or hepatitis infection.
Research Study Groups:
This trial has the following groups:- Group 1: 150 mg of Grape Seed Extract (GSE)
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Share this study with friends
Copy Link
Messenger